Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers discovered that blocking the PSGL-1 protein with meds promoted an anti-tumor immune response in people with melanoma.
University of California San Francisco researchers uncover common immune microenvironments across different types of cancer.
Oncogenic mutations are common, and vary in different tissue types, before people develop cancer.
A look at the symptoms, treatments, risk factors, prognosis and research on breast cancer metastasis to the brain.
New skin graph techniques result in pigmented tissue that better matches the cancer patients’ facial color.
Damon Runyon Cancer Research Foundation scientists work to develop drugs for people with KRAS-driven cancers.
Among babies with Beckwith-Wiedemann Syndrome, scientist are identifying which genetic changes are more likely to cause cancers.
A novel clinical trial based on research from Cleveland Clinic’s Lerner Research Institute targets triple-negative breast cancer.
Classifying atypical EGFR mutations into a new system of subgroups can point to the most effective lung cancer treatment.
A unique analysis measures treatment-free survival after immunotherapy in patients with advanced renal cell carcinoma.
Soheil Meshinchi, MD, PhD, discusses developing personalized therapies for the deadliest childhood leukemia that have fewer side effects.
Lauded actor, activist and rap artist Common stars in a PSA to raise awareness about lung cancer research and clinical trials.
People with lung cancer often face stigma. Researcher Jamie Studts explains how a new intervention aims to improve their quality of life.
Study findings from the Dana-Farber Cancer Institute arrive as colorectal cancer rates are increasing among younger people.
Adding ibrutinib to chemotherapy prolongs survival for younger people with a specific type of lymphoma.
Cancer vaccines become much more potent in their cancer-fighting abilities when combined with more established immunotherapies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.